Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast

Squamous cell carcinoma (SCC) of the breast is a rare malignancy that usually has a triple-negative phenotype and poor clinical outcomes. Because HER2-positive SCC of the breast is extremely rare, its clinicopathologic features are understudied, and the effects of neoadjuvant chemotherapy including...

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Yuki, Matsunuma, Ryoichi, Yamaguchi, Kei, Hayami, Ryosuke, Muramatsu, Aya, Suzuki, Makoto, Tsuneizumi, Michiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613576/
https://www.ncbi.nlm.nih.gov/pubmed/34899248
http://dx.doi.org/10.1159/000519746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613576/
https://www.ncbi.nlm.nih.gov/pubmed/34899248
http://dx.doi.org/10.1159/000519746

Ejemplares similares